Physician profile
Daniel Hunter Roeter
NPI 1386955870
$6,938.53
in general payments reported to CMS, 2019-2025
53 companies · $1,529 in 2025
The $1,529 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,115 · 2020: $269 · 2021: $505 · 2022: $1,360 · 2023: $925 · 2024: $1,235 · 2025: $1,529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,624 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,624.35 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $802.27 | 2019-2025 | Erleada |
| Boston Scientific Corporation | $770.66 | 2019-2025 | Lithovue, General - Kidney Stone Disease |
| Sumitomo Pharma America, INC. | $492.44 | 2023-2025 | Gemtesa, Orgovyx |
| Medtronic, INC. | $489.45 | 2021-2025 | Interstim |
| Dendreon Pharmaceuticals LLC | $419.80 | 2019-2025 | Provenge |
| Abbvie INC. | $330.30 | 2019-2025 | Lupron Depot |
| Pfizer INC. | $230.34 | 2019-2025 | |
| 180 Medical, INC. | $225.44 | 2020-2025 | Cure Catheter |
| Astellas Pharma US INC | $216.93 | 2021-2024 | Xtandi, Veozah, Myrbetriq |
| Coloplast Corp | $195.02 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $190.59 | 2019-2025 | Adstiladrin |
| Rochester Medical Corporation | $165.41 | 2022 | |
| Urovant Sciences INC | $164.19 | 2021-2022 | |
| Urogen Pharma, INC. | $153.55 | 2021-2025 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $142.18 | 2019-2025 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $132.05 | 2019-2023 | Aveed, Xiaflex |
| Sun Pharmaceutical Industries INC. | $98.14 | 2022-2024 | Yonsa |
| C. R. Bard, INC. & Subsidiaries | $96.61 | 2023-2024 | Bard Urinary Drainage Bag |
| Progenics Pharmaceuticals, INC. | $95.60 | 2021-2025 | Pylarify |
| Laborie Medical Technologies Corp. | $92.94 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter, Urgent PC Neuromodulation System |
| Merck Sharp & Dohme LLC | $90.43 | 2019-2025 | Keytruda, Lynparza |
| Tempus Ai, INC | $85.95 | 2025 | Xt Cdx |
| Myovant Sciences INC. | $84.73 | 2021-2022 | |
| Olympus America INC. | $77.88 | 2024-2025 | Itind System, Soltive |
| Tolmar Pharmaceuticals, INC. | $75.38 | 2020-2022 | |
| Janssen Scientific Affairs, LLC | $73.40 | 2019-2020 | |
| Blue Earth Diagnostics | $73.01 | 2019-2021 | |
| Antares Pharma, INC. | $66.37 | 2022-2023 | Nocdurna, Xyosted, Tlando |
| Accord Healthcare, INC. | $64.23 | 2024 | |
| Novartis Pharmaceuticals Corporation | $63.24 | 2024-2025 | |
| Teleflex LLC | $61.85 | 2023-2025 | Urolift, Deknatel |
| Tolmar, INC. | $51.89 | 2025 | Jatenzo, Eligard |
| Travere Therapeutics, INC. | $51.08 | 2019-2022 | |
| Convatec INC. | $46.44 | 2022 | |
| Procept Biorobotics Corporation | $43.59 | 2022-2024 | Aquabeam System |
| Medtronic USA, INC. | $42.56 | 2019 | |
| Trevena, INC. | $39.18 | 2022 | |
| Telix Pharmaceuticals | $39.09 | 2024-2025 | Illuccix |
| Therapeuticsmd, INC. | $36.45 | 2020 | |
| Amgen INC. | $35.04 | 2019 | |
| Myriad Genetic Laboratories, INC. | $27.83 | 2021-2023 | Precisetumor |
| Bioprotect Medical, INC. | $25.04 | 2025 | Bioprotect Balloon Implant System |
| Becton, Dickinson and Company | $23.78 | 2024 | Bard Urinary Drainage Bag |
| Calyxo, INC. | $22.54 | 2024 | Cvac Aspiration System |
| Profound Medical Corp. | $16.78 | 2022 | |
| Ethicon US, LLC | $16.08 | 2019 | |
| Ambu INC. | $15.89 | 2022 | |
| Photocure INC | $15.19 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.91 | 2023 | Seglentis |
| Angiodynamics, INC. | $14.57 | 2023 | Nanoknife |
| Axonics, INC. | $14.55 | 2021 | |
| Alnylam Pharmaceuticals INC. | $13.27 | 2021 | |
| Allergan, INC. | $12.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Roeter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.